Howard Hughes Medical Institute’s Trip.com Group TCOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-9,584
Closed -$446K 171
2016
Q3
$446K Sell
9,584
-26
-0.3% -$1.16K 0.11% 96
2016
Q2
$396K Buy
9,610
+4,347
+83% +$190K 0.13% 98
2016
Q1
$233K Sell
5,263
-8,133
-61% -$340K 0.05% 106
2015
Q4
$621K Sell
13,396
-2,466
-16% -$113K 0.09% 89
2015
Q3
$501K Buy
15,862
+3,476
+28% +$121K 0.09% 94
2015
Q2
$450K Buy
12,386
+6,964
+128% +$243K 0.1% 102
2015
Q1
$159K Buy
+5,422
New +$131K 0.02% 134
2014
Q4
Sell
-1,788
Closed -$51K 190
2014
Q3
$51K Buy
+1,788
New +$56.8K 0.01% 155
2014
Q2
Sell
-200,000
Closed -$5.04M 227
2014
Q1
$5.04M Hold
200,000
0.72% 27
2013
Q4
$4.96M Hold
200,000
0.75% 31
2013
Q3
$5.84M Buy
+200,000
New +$4.3M 0.89% 23

Other funds holding TCOM

Howard Hughes Medical Institute's TCOM Position: Q4 2016 in Review

Howard Hughes Medical Institute sold out of Trip.com Group (TCOM) in Q4 2016, closing a stake of 9,584 shares — an estimated $446K sold.

Howard Hughes Medical Institute first reported a position in TCOM in Q3 2013 and held it in 11 quarters. The position peaked at $5.84M in Q3 2013. 372 funds tracked by Wall St. Rank hold TCOM as of Q4 2016.

  • Howard Hughes Medical Institute reported no remaining Trip.com Group position as of Q4 2016 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 9,584 Trip.com Group shares in Q4 2016, an estimated $446K.
  • Howard Hughes Medical Institute first reported a position in Trip.com Group in Q3 2013 and held it in 11 quarters.
  • Howard Hughes Medical Institute's Trip.com Group position peaked at $5.84M in Q3 2013.
  • 372 funds tracked by Wall St. Rank held Trip.com Group as of Q4 2016.

Based on Howard Hughes Medical Institute's 13F filing for Q4 2016, filed 1 Feb 2017.